Moreover, in AKI, Memo1 does not significantly alter the development of the disease, but a heterogeneity of findings was present in sex‐disaggregated analyses that was in line with the renal findings of kidney injury biomarker Kim‐1. This evidence concerns the gene MEMO1 and acute kidney injury.